Cargando…
Evaluation of Second Primary Cancer Risk Among Chronic Lymphocytic Leukemia Patients: Multicenter Study
BACKGROUND: Patients with chronic lymphocytic leukemia (CLL) have an increased risk of developing second primary cancers (SPC). The aim of this study is to determine the frequency of SPC in CLL patients and determine the relationship between these cancers and their treatment status, cytogenetic fact...
Autores principales: | Sayin, Selim, Kiliacslan, Emrah, Yildirim, Murat, Ozturk, Hacer Berna Afacan, Yilmaz, Esra Safak, Albayrak, Murat, Kaptan, M. Kursat, Ayli, Meltem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505873/ https://www.ncbi.nlm.nih.gov/pubmed/37378926 http://dx.doi.org/10.31557/APJCP.2023.24.6.1971 |
Ejemplares similares
-
The Effect of Platelet and Mean Platelet Volume Levels on Standard-dose Methylprednisolone Treatment Response in Primary Immune Thrombocytopenia
por: KILICASLAN, Emrah, et al.
Publicado: (2023) -
Effect of Blood Groups on Clinical Presentations and Treatment Outcomes in Immune Thrombotic Thrombocytopenic Purpura Patients with Severe ADAMTS13 Deficiency: A Multi-Center Experience
por: Yıldırım, Murat, et al.
Publicado: (2022) -
RECURRENT AUTOIMMUNE HEMOLYTIC ANEMIA AFTER MRNA COVID-19 VACCINE (PFIZER-BIONTECH)
por: YILMAZ, Fatma, et al.
Publicado: (2021) -
The outcome of COVID-19 in patients with hematological malignancy
por: Tığlıoğlu, Pınar, et al.
Publicado: (2021) -
DOES BLOOD TYPE HAVE AN EFFECT ON THE COURSE OF COVID-19?
por: YILMAZ, Fatma, et al.
Publicado: (2021)